The Governors' Right to Inspect Act of 2026 allows state governors and designated public health officials to enter federal immigration detention facilities to check conditions related to health, safety, sanitation, and medical care. This authority applies to all U.S. detention centers, whether run directly by the government or by private contractors, and permits inspectors to review records and interview detainees who wish to speak privately. While the law grants access to inspect physical conditions, it explicitly prevents state officials from interfering with immigration enforcement, custody decisions, or the release of any detained individuals. Facility operators must cooperate with these inspections, and governors may submit their findings to Congress and the public, requiring a response from the Department of Homeland Security within 60 days.
The Health and Location Data Protection Act of 2026 prohibits data brokers from buying, selling, or sharing specific types of personal information, including an individual's health data and location history. This ban applies to any entity that resells data it did not collect directly from the person, though it allows exceptions for actions compliant with existing HIPAA rules, newsworthy reporting, and disclosures where the individual has given valid consent. The Federal Trade Commission is tasked with defining exactly what counts as "data" and issuing final rules within 180 days of the law's enactment. Violations of these restrictions can lead to enforcement actions by the FTC, state attorneys general, or private individuals, potentially resulting in civil penalties of up to 15 percent of the violator's annual revenue. The legislation also includes a funding provision that appropriates $1 billion to the FTC for fiscal year 2027 to support its work under this act.
The Prices on the Wall Act of 2026 requires hospitals, ambulatory surgical centers, laboratories, and imaging providers across the United States to display specific pricing information on their walls starting in 2028. This law mandates that these facilities post discounted cash prices for a list of services designated by the Centers for Medicare & Medicaid Services, or if those prices are unavailable, the median amount charged to self-pay patients over the previous three years. The displayed prices must be located in areas specified by the Secretary of Health and Human Services to ensure patients can see costs before receiving care. By making these financial details publicly visible, the bill aims to increase price transparency for consumers seeking scheduled medical services.
The Freedom to Travel for Health Care Act of 2026 prohibits any person or government entity from restricting, sanctioning, or discriminating against individuals who travel to another state to receive reproductive health care that is legal there. It also protects those who assist travelers and reproductive health care providers from facing penalties for offering services to out-of-state patients, effectively overriding any conflicting state laws. The bill establishes a private right of action allowing affected individuals, organizations, and providers to sue in federal or state court for violations, with provisions for damages and attorney's fees. Additionally, it removes state sovereign immunity defenses for officials enforcing laws that interfere with this travel right, ensuring federal courts can hear such cases directly.
The Fair Care Act of 2026 is a comprehensive legislative proposal designed to lower health care costs and improve access by modernizing health savings accounts, expanding insurance coverage options, and increasing transparency in the health care market. The bill directly affects individuals, employers, health insurance issuers, hospitals, and pharmaceutical manufacturers through provisions that allow unused premium tax credits to be deposited into savings accounts, introduce new "copper" insurance plans, and require greater price transparency for hospitals and pharmacy benefit managers. Key mechanisms include the repeal of the employer health insurance mandate, the establishment of a federal reinsurance pool for high-risk individuals, the creation of a conditional approval pathway for drugs treating rare and serious diseases, and the imposition of congressional review procedures for major Food and Drug Administration rules. Additionally, the legislation seeks to promote competition by banning anticompetitive contract terms, regulating co-pay contributions from drug manufacturers, and enforcing stricter price reporting requirements for shoppable medical procedures.
This bill requires the Department of Veterans Affairs and the Department of Defense to study how military sexual trauma and intimate partner violence increase the risk of suicide among service members and veterans. Within 18 months of passing, these agencies must submit a report and briefing to Congress and the public detailing these findings. A year after the report is released, the departments must update their clinical suicide prevention guidelines to include these specific risk factors. The legislation directly affects military personnel, veterans, and the agencies responsible for their healthcare and safety protocols.
The VA Health Care Capacity Assessment Act requires the Department of Veterans Affairs to submit biennial reports every two years to Congress regarding the staffing levels at its medical facilities. These reports must detail current wait times and workload for specific clinics, including mental health and primary care, alongside an assessment of whether staffing levels are sufficient to meet patient access goals. The legislation also mandates that the reports include a plan to address any identified staffing issues, analyze succession planning and vacancy rates, and describe how the department intends to use direct appointment authority to fill shortages. Ultimately, this bill aims to increase transparency by providing Congress with concrete data on the VA's workforce capacity and strategies for maintaining adequate healthcare services for veterans.
The Latonya Reeves Freedom Act of 2026 strengthens the Americans with Disabilities Act to ensure individuals with long-term care needs have a federally protected right to live in their own homes or integrated community settings rather than institutions. It mandates that states and insurance providers offer community-based services, provide maximum control over care choices to individuals, and establish enforceable plans to transition people out of institutional facilities. The bill also creates new enforcement mechanisms, including a task force to study barriers to community living, requirements for public participation in planning, and the ability for individuals to sue for damages if they are denied these community-based options.
This joint resolution seeks to officially disapprove a specific rule issued by the Centers for Medicare & Medicaid Services regarding the implementation of prior authorization for certain Medicare services. The proposed action would prevent the rule, known as the WISeR Model, from taking effect, thereby stopping the new requirements from being enforced. If passed, the resolution would nullify the regulation and maintain the status quo for the affected healthcare services.
This resolution expresses the sense of Congress that Medicaid is a vital lifeline for the health care of millions of Americans, including older adults, people with disabilities, and low-income families. It highlights concerns that recent legislation will cut funding and impose new eligibility rules and paperwork requirements, which could negatively impact access to care. While the bill itself does not change laws or allocate money, it urges the Centers for Medicare & Medicaid Services to provide immediate guidance to state agencies and enrollees regarding these upcoming changes.